Jain P, Wang M (2019) Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol 94(6):710–725

Article  PubMed  Google Scholar 

Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66(6):443–459

Article  PubMed  Google Scholar 

Smedby KE, Hjalgrim H (2011) Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol 21(5):293–298

Article  PubMed  Google Scholar 

Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M, Committee EG (2017) Newly diagnosed and relapsed mantle cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals Oncol Off J Eur Soc Med Oncol 28(suppl_4):iv62–iv71

Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A, Trneny M, Geisler CH, Di Raimondo F, Szymczyk M et al (2014) Confirmation of the mantle-cell lymphoma international prognostic index in randomized trials of the European Mantle-Cell Lymphoma Network. J Clin Oncol 32(13):1338–1346

Article  PubMed  Google Scholar 

Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H et al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558–565

Article  CAS  PubMed  Google Scholar 

Yan X, Zhou Y, Huang S, Li X, Yu M, Huang J, Wang J, Ma Z, Jin J, Pan J et al (2018) Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma. J Cancer Res Clin Oncol 144(4):697–706

Article  CAS  PubMed  Google Scholar 

Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J et al (2020) Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136(12):1419–1432

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi S, Yan Y, Jin M, Bhattacharya S, Wang Y, Wu Y, Yang L, Gine E, Clot G, Chen L et al (2022) Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma. J Clin Investig 132(3)

Rule S, Dreyling M, Goy A, Hess G, Auer R, Kahl B, Hernandez-Rivas JA, Qi K, Deshpande S, Parisi L et al (2019) Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis. Haematologica 104(5):e211–e214

Medvedovic J, Ebert A, Tagoh H, Busslinger M (2011) Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol 111:179–206

Article  CAS  PubMed  Google Scholar 

Zheng L, He J, Li M, Yuan H, Li H, Hu F, Chen L, Tang W, Sheng M (2022) Clinical significance and mechanism of long noncoding RNA HAGLROS in triple negative breast cancer. Pathol Res Pract 231:153810

Article  CAS  PubMed  Google Scholar 

Haghverdi MK, Moslemi E (2018) Expression rate and PAX5 gene methylation in the blood of people suffering from gastric cancer. Open Access Maced J Med Sci 6(9):1571–1576

Article  PubMed  PubMed Central  Google Scholar 

Ren Y, Hou J, Xu A, Pan Y (2015) Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer. Int J Clin Exp Pathol 8(11):14709–14716

PubMed  PubMed Central  Google Scholar 

Zhang N, Li Z, Bai F, Zhang S (2019) PAX5-induced upregulation of IDH1-AS1 promotes tumor growth in prostate cancer by regulating ATG5-mediated autophagy. Cell Death Dis 10(10):734

Article  PubMed  PubMed Central  Google Scholar 

Sun D, Li F, Liu L, Yu S, Wang H, Gao X, Liu G, Zhao Y, Qiu G, Jiang X (2022) PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1. Aging 14(1):509–525

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calderón L, Schindler K, Malin SG, Schebesta A, Sun Q, Schwickert T, Alberti C, Fischer M, Jaritz M, Tagoh H et al (2021) Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation. Sci Immunol 6(61)

National Comprehensive Cancer Network. (NCCN) Clinical Practice Guidelines in Oncology. B-cell lymphomas, Version 2.2022. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed 21 Mar 2022

Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10(1):1523

Article  PubMed  PubMed Central  Google Scholar 

Vogt N, Dai B, Erdmann T, Berdel WE, Lenz G (2017) The molecular pathogenesis of mantle cell lymphoma. Leuk Lymphoma 58(7):1530–1537

Article  CAS  PubMed  Google Scholar 

Sander B, Quintanilla-Martinez L, Ott G, Xerri L, Kuzu I, Chan JK, Swerdlow SH, Campo E (2016) Mantle cell lymphoma–a spectrum from indolent to aggressive disease. Virchows Archiv An Int J Pathol 468(3):245–257

Article  CAS  Google Scholar 

Demajo S, Albero R, Clot G, Castellano G, Navarro A, Capdevila C, Enjuanes A, Nadeu F, Gine E, Pinyol M et al (2021) A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma. Clin Cancer Res An Off J Am Assoc Cancer Res 27(1):213–225

Article  CAS  Google Scholar 

Scott DW, Abrisqueta P, Wright GW, Slack GW, Mottok A, Villa D, Jares P, Rauert-Wunderlich H, Royo C, Clot G et al (2017) New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies. J Clin Oncol Off J Am Soc Clin Oncol 35(15):1668–1677

Article  CAS  Google Scholar 

Xu DM, Liang JH, Wang L, Zhu HY, Xia Y, Fan L, Li JY, Xu W (2020) 25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma. J Cancer Res Clin Oncol 146(4):1003–1009

Article  CAS  PubMed  Google Scholar 

Grey HM, Kubo RT, Colon SM, Poulik MD, Cresswell P, Springer T, Turner M, Strominger JL (1973) The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med 138(6):1608–1612

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoo C, Yoon DH, Yoon S, Kim S, Huh J, Park CJ, Lee SW, Suh C (2015) Prognostic impact of beta(2)-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 56(3):688–693

Article  CAS  PubMed  Google Scholar 

Yoo C, Yoon DH, Suh C (2014) Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor. Blood Res 49(3):148–153

Article  PubMed  PubMed Central  Google Scholar 

Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M et al (2019) CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis. Hum Pathol 89:71–80

Article  CAS  PubMed  Google Scholar 

Rothenberg EV (2014) Transcriptional control of early T and B cell developmental choices. Annu Rev Immunol 32:283–321

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias JW, Metzgar MH, Paterson J, Erikson J, Marafioti T et al (2007) B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Investig 117(9):2602–2610

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song HR, Guo XB, Duan Y, Meng HY, Wang ZY (2021) PAX5-induced upregulation of LINC01194 exerts oncogenic properties by regulating GOLPH3 expression via miR-486-5p in prostate cancer. Eur Rev Med Pharmacol Sci 25(6):2528–2541

PubMed  Google Scholar 

Wu X, Xiao Y, Zhou Y, Zhou Z, Yan W (2019) LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death Dis 10(7):472

Article  PubMed  PubMed Central  Google Scholar 

Wang D, Chen J, Li R, Wu G, Sun Z, Wang Z, Zhai Z, Fang F, Guo Y, Zhong Y et al (2016) PAX5 interacts with RIP2 to promote NF-kappaB activation and drug-resistance in B-lymphoproliferative disorders. J Cell Sci 129(11):2261–2272

CAS  PubMed  Google Scholar 

Vouyovitch CM, Vidal L, Borges S, Raccurt M, Arnould C, Chiesa J, Lobie PE, Lachuer J, Mertani HC (2008) Proteomic analysis of autocrine/paracrine effects of human growth hormone in human mammary carcinoma cells. Adv Exp Med Biol 617:493–500

Article  CAS  PubMed  Google Scholar 

Cobaleda C, Jochum W, Busslinger M (2007) Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449(7161):473–477

Article  CAS  PubMed  Google Scholar 

Hosokawa K, Ishimaru H, Watanabe T, Fujimuro M (2021) Pax5 mediates the transcriptional activation of the CD81 gene. Sci Rep 11(1):22919

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ranganathan P, Weaver KL, Capobianco AJ (2011) Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11(5):338–351

Article  CAS  PubMed  Google Scholar 

Gu Y, Masiero M, Banham AH (2016) Notch signaling: its roles and therapeutic potential in hematological malignancies. Oncotarget 7(20):29804–29823

Article  PubMed  PubMed Central  Google Scholar 

Silkenstedt E, Arenas F, Colom-Sanmartí B, Xargay-Torrent S, Higashi M, Giró A, Rodriguez V, Fuentes P, Aulitzky WE, van der Kuip H et al (2019) Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. J Exp Clin Cancer Res 38(1):446

Article  PubMed  PubMed Central  Google Scholar